A Biotech ETF for Up-and-Coming Drug Developers

I do the “ETF of the Week” for MarketWatch every Thursday on Chuck Jaffe’s MoneyLife Show where I highlight big movers and disappointments within the exchange traded fund market.

This Thursday, I took a look at the SPDR S&P Biotech ETF (NYSEArca: XBI). Instead of betting on a few small up-and-coming biotechnology firms, this equal-weight biotech ETF helps provide a diversified approach to the industry.

Click here to listen to the podcast.

To access previous podcasts, take a look at our podcasts category.

Categories: Featured, Podcasts
Tags: , , , , , , , , , ,

Post Comment